IL-6/GP130 receptor antagonists (Ohio state university/Ohio State University Technology Commercialization and Knowledge Transfer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIL-6/GP130 receptor antagonists (Ohio state university/Ohio State University Technology Commercialization and Knowledge Transfer)
Drug Alias NameMDL-16 (Ohio State University)MDL-5 (Ohio State University)MDL-5MDL-16
ClassificationSmall molecules
Mechanisms of ActionAminopeptidase N inhibitorsIL-6 receptor antagonists
TargetsAminopeptidase NIL-6 receptor
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Ohio State University
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A